Mologic

LONDON: Avacta Group has entered into a commercial partnership with Mologic Ltd to accelerate to market Avacta’s AffiDX SARS-CoV-2 lateral flow rapid antigen test. Avacta will also support antigen testing in low and middle income countries by providing access to…